Daten aus dem Cache geladen. Plasmid DNA Manufacturing Market is Estimated to Witness High...

Plasmid DNA Manufacturing Market is Estimated to Witness High Growth Owing to Technological Advancements in DNA Synthesis

0
404

Plasmid DNA is circular DNA molecules that can replicate independently of the chromosomal DNA within a cell. Plasmid DNA is employed extensively in research, bioproduction, and gene and cell therapies. Plasmid DNA manufacturing involves steps like cloning, amplification, purification, and analyzing the quality of plasmid DNA. Advances in DNA synthesis such as Gibson assembly, droplet microfluidics, and next-generation gene editing tools have enabled rapid engineering and manufacturing of custom plasmids. The rising number of gene and cell therapy clinical trials have created substantial demand for GMP-grade plasmid DNA.

The Global Plasmid DNA Manufacturing Market is estimated to be valued at US$ 1038.19 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Plasmid DNA Manufacturing are Cobra Biologics and Pharmaceutical Services (Charles River Laboratories), VGXI, Inc., Aldevron (Danaher), Kaneka Corporation, Nature Technology, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult, LakePharma, Inc., MeiraGTx Limited, Eurofins Genomics, Vigene Biosciences, Luminous BioSciences (LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio (AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc., Altogen Biosystems, Puresyn, Inc., Cepham Life Sciences, Catalent, Inc., Biomiga, Waisman Biomanufacturing. Key opportunities in the market include the rising demand for plasmid vectors from biopharmaceutical companies and CMOs for gene and cell therapy development and production. Advancements like Gibson assembly and microfluidics are enabling rapid, scalable plasmid engineering and manufacturing.

Market Drivers
The Plasmid DNA Manufacturing Market Trends of gene and cell therapy clinical trials, rising demand for plasmid vectors for vaccine development against COVID-19 and other diseases, and focus on genome editing and DNA synthesis technologies for developing novel therapeutics. The focus of biopharma companies and researchers on DNA vaccines and gene therapies to treat cancers, genetic disorders, and infectious diseases is expected to significantly drive the demand for plasmid DNA over the forecast period.
Challenges in the plasmid DNA manufacturing market

Get More Insights On, Plasmid DNA Manufacturing Market

Search
Categories
Read More
Other
Microbial Rennet Market to witness market growth at a rate of 7.05%,
The market analysis furnishes insights into the drivers and restraints affecting...
By Kirsten Scott 2024-07-29 11:10:01 0 541
Other
1060 and 3003 aluminium spherical circles
Each 1060 aluminum circle and 3003 aluminum circle are everyday participants of...
By Xuanxuan Geng 2024-05-13 05:54:03 0 704
Crafts
The Timeless Appeal of Rings Mirror Acrylic Wall Décor by Londoncrafts
In the world of interior design, the details often define the space. From the colors of the walls...
By London Crafts 2024-09-21 10:44:21 0 287
Health
All Day Slimming Tea (Scam Or Not) Lose Your Fat Easily With It!
➢Product Review: — All Day Slimming Tea ➢Used For:  —Weight Reduction ➢Main...
By Logan Woolner 2023-12-11 06:29:19 0 1K
Food
Foremost 15 Transforming Temperature Sweeteners Market
Polaris Market Research has recently added the latest research report titled Sweeteners Market...
By Sakshi Thakur 2024-11-19 04:42:47 0 91